COVID-19: With half a dozen vaccines, India presses the accelerator
Hyderabad, Aug. 31 -- M Somasekhar
The Indian drug regulator's nod to ZyCoV-D, the first vaccine against COVID-19, which is claimed to be effective for children above 12 years and all adults, could well mark an important milestone in managing the pandemic.
The Ahmedabad-based, Zydus Cadila, which has indigenously developed it says, it's the world's first human DNA vaccine (Deoxyribonucleac acid) against COVID-19. It has gone through human trials of over 28,000 people, including over a 1000 adolescents between ages 12-18,with encouraging results.
With this, India now has half a dozen vaccines which have been given the emergency authorisation by the Drug Controller General of India (DGCI). It means both access and growing numbers of vacc...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.